Blocking SRC Protein Slows Vascular Aging by Boosting Cellular Cleanup
New research reveals how inhibiting SRC protein enhances mitochondrial cleanup in blood vessels, potentially slowing cardiovascular aging.
Summary
Scientists discovered that blocking a protein called SRC can slow aging in blood vessels by improving cellular cleanup processes. In studies using mice and cell cultures, researchers found that SRC interferes with mitophagy - the process cells use to remove damaged mitochondria. When SRC was inhibited with a drug called KX2-391, blood vessels showed less aging, better mitochondrial health, and reduced atherosclerotic plaque formation. The protective effect works through another protein called FUNDC1, which becomes more active when SRC is suppressed. This enhanced cellular cleanup helps prevent vascular smooth muscle cells from becoming senescent, maintaining healthier blood vessels overall.
Detailed Summary
Vascular aging is a critical factor in cardiovascular disease, driven largely by the accumulation of senescent cells in blood vessel walls. This groundbreaking study reveals a new pathway that could be targeted to slow this aging process and protect heart health.
Researchers investigated the role of SRC, a stress-responsive protein, in vascular aging using both laboratory cell cultures and live mouse models. They created accelerated aging conditions in ApoE-deficient mice using high-fat diets and chemical treatments, while inducing cellular senescence in vascular smooth muscle cells with doxorubicin.
The key discovery was that elevated SRC levels impair mitophagy - the cellular process that removes damaged mitochondria. When researchers blocked SRC using the inhibitor KX2-391, they observed remarkable improvements: reduced vascular aging markers, better mitochondrial structure, decreased atherosclerotic plaque burden, and more stable arterial walls. The mechanism involves SRC's interaction with FUNDC1, a protein essential for mitophagy.
These findings suggest that targeting SRC could offer a novel therapeutic approach for preventing cardiovascular aging. By enhancing the cell's ability to clear damaged mitochondria, SRC inhibition helps maintain healthier blood vessels and potentially reduces atherosclerosis risk. This research opens new possibilities for interventions that could extend cardiovascular healthspan and reduce age-related heart disease.
Key Findings
- SRC protein inhibition reduced vascular aging markers and improved mitochondrial health in blood vessels
- Drug KX2-391 decreased atherosclerotic plaque formation and enhanced arterial wall stability
- SRC suppression enhanced mitophagy through activation of FUNDC1 protein pathway
- Blocking SRC prevented vascular smooth muscle cell senescence in laboratory studies
Methodology
Study used ApoE-deficient mice with high-fat diet and streptozotocin to model accelerated vascular aging, plus mouse aortic vascular smooth muscle cells treated with doxorubicin for senescence. SRC was inhibited using KX2-391 drug and genetic knockdown techniques.
Study Limitations
Study conducted only in mouse models and cell cultures, requiring human clinical validation. Long-term safety and efficacy of SRC inhibition in humans remains unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.